Irish team begin COVID drug therapy trial

Irish scientists have begun a clinical trial for a drug therapy that could be beneficial for people who are critically ill in intensive care with COVID-19.
A team from the Royal College of Surgeons in Ireland (RCSI) has begun a controlled clinical trial involving alpha-1-antitrypsin. This is a naturally occurring human protein that is produced by the liver and released into the bloodstream. It normally acts to protect the lungs from the destructive actions of common illnesses.
The RCSI trial i


Source link

You might also like

Leave a Reply